Figures & data
Figure 1. iBIM framework.
* NSCLC, pancreatic cancer, CRC, MTC, TC, salivary gland cancer, cholangiocarcinoma, gastric cancer, small intestine cancer, ovarian cancer, breast cancer, prostate cancer, xanthogranuloma, melanoma skin cancer, non-melanoma skin cancer, sarcoma, pulmonary carcinosarcoma, carcinoid, carcinoma of unknown primary.
Abbreviations: CRC, colorectal cancer; NSCLC, non-small cell lung cancer; MTC, medullary thyroid cancer; TC, thyroid cancer.
![Figure 1. iBIM framework.* NSCLC, pancreatic cancer, CRC, MTC, TC, salivary gland cancer, cholangiocarcinoma, gastric cancer, small intestine cancer, ovarian cancer, breast cancer, prostate cancer, xanthogranuloma, melanoma skin cancer, non-melanoma skin cancer, sarcoma, pulmonary carcinosarcoma, carcinoid, carcinoma of unknown primary.Abbreviations: CRC, colorectal cancer; NSCLC, non-small cell lung cancer; MTC, medullary thyroid cancer; TC, thyroid cancer.](/cms/asset/d0b2cf2d-9a14-4191-84b4-881df548b52c/ijme_a_2317120_f0001_b.jpg)
Table 1. Estimated patient population per million.
Figure 3. OWSA, base-case – commercial perspective (Y1).
Abbreviations: 1L, first-line; 2L+, second-line and beyond; CRC, colorectal cancer; NSCLC, non-small cell lung cancer; RET, REarranged during Transfection; Y1, year 1.
![Figure 3. OWSA, base-case – commercial perspective (Y1).Abbreviations: 1L, first-line; 2L+, second-line and beyond; CRC, colorectal cancer; NSCLC, non-small cell lung cancer; RET, REarranged during Transfection; Y1, year 1.](/cms/asset/eeec6c2b-6d87-473f-9040-d6cbd3eb199e/ijme_a_2317120_f0003_c.jpg)
Figure 4. OWSA, base-case – Medicare perspective (Y1).
Abbreviations: 1L, first-line; 2L+, second-line and beyond; CRC, colorectal cancer; NSCLC, non-small cell lung cancer; RET, REarranged during Transfection; Y1, year 1.
![Figure 4. OWSA, base-case – Medicare perspective (Y1).Abbreviations: 1L, first-line; 2L+, second-line and beyond; CRC, colorectal cancer; NSCLC, non-small cell lung cancer; RET, REarranged during Transfection; Y1, year 1.](/cms/asset/0e634dac-6d85-4e2b-a46c-fd12f323c626/ijme_a_2317120_f0004_c.jpg)
Table 2. Scenario analyses.
Supplemental Material
Download MS Word (1.3 MB)Data sharing statement
The integrated budget impact model could be available to health care decision makers, healthcare organizations, and third party payers by contacting The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979).